In recent weeks, the PDL Professional Officers have received a number of queries regarding pharmacists’ obligations and liability when dispensing Mounjaro® (tirzepatide). Tirzepatide is a
The PDL Professional Officers often manage calls, incident reports and occasional regulatory complaints following a pharmacist’s decision to decline supply of a medication. Recently, the
PDL is raising awareness with hospital pharmacists about the need to report incidents to PDL. This call has been prompted by a recent review of
Pharmacists are at the forefront of patient care, ensuring the safe and effective use of medications. Despite pharmacists best efforts, incidents can result in complaints,
Notice is hereby given that the 111th Annual General Meeting of Pharmaceutical Defence Limited will be a hybrid meeting, both in person at Suite 3,
The annual R U OK?Day is a reminder that a conversation can change a life. So, PDL would like to take a moment to check
PDL Professional Officers occasionally receive incident reports and notifications relating to breaches or concerns regarding access to a patient’s My Health Record. Some of these
PDL is pleased to announce the opening of the 2023 Student Grant Program, with applications open until the end of August. The grants program was
PDL Professional Officers continue to receive enquiries and incident reports that have contributing factors such as pressure, stress, workload or fatigue. PDL recognises the high
Pharmacists are in a unique position of trust. That trust requires pharmacists to respect and protect the privacy of those under their care. Patient information
Pharmaceutical Defence Limited (PDL) acknowledges the Traditional Owners of Country throughout Australia and their continuing connection to land, waters and community. We pay our respects to the people, the cultures and the Elders past and present.